Skip to Main Content
Try STAT+ TODAY
Trending:
Health
Biotech
STAT+
First Opinion
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Pharmalot
STAT+

Trump promised drug makers would lower their prices, but not every company got the memo

  • Ed Silverman

By Ed Silverman July 3, 2018

Reprints
Mark Lennihan/AP

On May 30, President Trump promised that “some” of the big drug makers would announce “voluntary, massive drops in prices” in two weeks.

But not everyone in the pharmaceutical industry got the memo.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Ed Silverman

Ed Silverman

Pharmalot Columnist, Senior Writer

Ed Silverman covers the pharmaceutical industry.

Tags

‘Everybody has blood on their hands’: A decade-long battle…
‘Everybody has blood on their hands’: A decade-long battle over Medicare Advantage audits is coming to…
Why doesn’t the U.S. have at-home flu tests?
Why doesn’t the U.S. have at-home flu tests?
Why fentanyl is deadlier than heroin, in a single…
Why fentanyl is deadlier than heroin, in a single photo
Medicare may test policy of paying less for accelerated…
Medicare may test policy of paying less for accelerated approval drugs
Pharmalittle: Amgen pricing for Humira biosimilar may not help…
Pharmalittle: Amgen pricing for Humira biosimilar may not help patients; pharma wins court battle over drug…
Amgen pricing for its Humira biosimilar may benefit PBMs…
Amgen pricing for its Humira biosimilar may benefit PBMs and insurers more than patients

Comments are closed.

Recommended Stories